1. Volume 58, Issue 4, Pages 1788-1796 (October 2000)
Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation 
François Pierre Westeel, Hakim Mazouz, Fatima Ezaitouni, Carine Hottelart, Christina Ivan, Patrice Fardellone, Michel Brazier, Isabelle El Esper, Jacques Petit, Jean Michel Achard, André Pruna, Albert Fournier 
Kidney International 
Volume 58, Issue 4, Pages (October 2000)
DOI: /j x
Copyright © 2000 International Society of Nephrology Terms and Conditions

2. Figure 1
Follow-up of bone remodeling markers (BRMs) (A) and treatment (B). Symbols are: (▪) parathyroid hormone; (□) osteocalcin; (▴) total alkaline phosphatase; (▵) bone alkaline phosphatase; (○) pyridinoline; (•) Deoxypyridinoline. Black boxes represent steroid doses.
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

3. Figure 2
Correlation of plasma osteocalcin increase at six months and mean trough level of cyclosporine during the first six months (P = 0.01; r = 0.48; N = 28).
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions